Genprex Inc (GNPX)
2.21
+0.09
(+4.25%)
USD |
NASDAQ |
Apr 26, 16:00
2.10
-0.11
(-4.98%)
After-Hours: 20:00
Genprex Market Cap: 4.222M for April 26, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 26, 2024 | 4.222M |
| April 25, 2024 | 4.05M |
| April 24, 2024 | 4.222M |
| April 23, 2024 | 4.413M |
| April 22, 2024 | 4.132M |
| April 19, 2024 | 4.069M |
| April 18, 2024 | 4.240M |
| April 17, 2024 | 4.222M |
| April 16, 2024 | 4.394M |
| April 15, 2024 | 4.489M |
| April 12, 2024 | 5.120M |
| April 11, 2024 | 5.311M |
| April 10, 2024 | 5.502M |
| April 09, 2024 | 5.865M |
| April 08, 2024 | 5.655M |
| April 05, 2024 | 5.731M |
| April 04, 2024 | 5.712M |
| April 03, 2024 | 5.941M |
| April 02, 2024 | 5.426M |
| April 01, 2024 | 5.674M |
| March 28, 2024 | 5.693M |
| March 27, 2024 | 5.177M |
| March 26, 2024 | 5.234M |
| March 25, 2024 | 5.731M |
| March 22, 2024 | 5.846M |
| Date | Value |
|---|---|
| March 21, 2024 | 5.769M |
| March 20, 2024 | 5.201M |
| March 19, 2024 | 5.900M |
| March 18, 2024 | 7.139M |
| March 15, 2024 | 6.003M |
| March 14, 2024 | 6.181M |
| March 13, 2024 | 6.226M |
| March 12, 2024 | 6.256M |
| March 11, 2024 | 6.984M |
| March 08, 2024 | 6.286M |
| March 07, 2024 | 6.315M |
| March 06, 2024 | 6.508M |
| March 05, 2024 | 6.122M |
| March 04, 2024 | 6.300M |
| March 01, 2024 | 6.657M |
| February 29, 2024 | 6.389M |
| February 28, 2024 | 6.196M |
| February 27, 2024 | 6.241M |
| February 26, 2024 | 6.553M |
| February 23, 2024 | 6.478M |
| February 22, 2024 | 6.538M |
| February 21, 2024 | 6.672M |
| February 20, 2024 | 6.374M |
| February 16, 2024 | 6.538M |
| February 15, 2024 | 6.508M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
4.05M
Minimum
Apr 25 2024
331.93M
Maximum
Feb 08 2021
80.31M
Average
68.19M
Median
Nov 14 2022
Market Cap Benchmarks
| Jaguar Health Inc | 51.70M |
| FibroGen Inc | 102.72M |
| BioXcel Therapeutics Inc | 80.42M |
| TFF Pharmaceuticals Inc | 7.360M |
| 4D Molecular Therapeutics Inc | 1.157B |
Market Cap Related Metrics
| Price to Book Value | 0.5693 |
| Price | 2.21 |
| Earnings Yield | -1.02K% |